11 авг 2020 г. - The US enters into a $1.5B deal with Moderna for 100 million doses of mRNA-1273, their lead candidate vaccine, to be priced at $15 per dose. The Phase III trial is still underway.
Добавлено на ленту времени:
Дата:
11 авг 2020 г.
Сейчас
~ 3 гг и 10 мес назад
